January 18, 2011
States deliver Stem Cell Funding in lean Times
January 3, 2011
Is there a January Effect
December 7, 2010
Proprietary Human Cell Detection Antibodies Launch, StemCells (STEM)
November 16, 2010
Stem Cell Venture Financings are back in Vogue
November 11, 2010
Underscoring the Need for Congressional Action, Stem Cell Research Advancement Act
October 5, 2010
Preclinical Acute Kidney Injury Study, Cytori Therapeutics (CYTX)
September 30, 2010
Stem Cells Identify Dangerous Side-Effects
September 24, 2010
Crohn's Disease Colitis Model, Epistem (LSE: EHP)
September 23, 2010
Legislation introduced for Regenerative Medicine
August 30, 2010
Judge Royce C Lamberth, Another Battleground
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.